Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido Lopez P, Gregorc V, Haakensen VD, Hiltermann TJN, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Siva S, Solomon B, Qiao Y, Anand S, Chander P, Shcherbakova T, Diaz Perez I, Filippi AR (2026)
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC
ESMO Open, 11 (2), 106070 (in press)
DOI 10.1016/j.esmoop.2026.106070, PubMed 41643268

Karlsson K, Rancati T, Lindbäck E, Lindberg S, Grozman V, Al-Jirf K, Lax I, Hoffmann L, Møller DS, Khalil A, Knap MM, Nielsen TB, Land LH, Kristiansen C, Ramberg C, Rogg LV, Hagen RK, Frøland AS, Drugge N, Nyman J, Josipovic M, Persson GF, Olofsson J, Bergström P, Rosenbrand HO et al. (2026)
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort
Int J Radiat Oncol Biol Phys (in press)
DOI 10.1016/j.ijrobp.2025.12.007, PubMed 41532892

Myhre PL, Helland Å, Myhr KM, Skogås JG, Langø T, Goll R, Vikse J, Fretland SØ (2026)
NorTrials drives growth in Norwegian clinical trials
Tidsskr Nor Laegeforen, 146 (1)
DOI 10.4045/tidsskr.25.0685, PubMed 41556676